Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Change in Inventory (2016 - 2025)

Historic Change in Inventory for China Pharma Holdings (CPHI) over the last 17 years, with Q3 2025 value amounting to -$57779.0.

  • China Pharma Holdings' Change in Inventory rose 8466.47% to -$57779.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$890206.0, marking a year-over-year increase of 3428.04%. This contributed to the annual value of -$1.6 million for FY2024, which is 952014.3% down from last year.
  • Latest data reveals that China Pharma Holdings reported Change in Inventory of -$57779.0 as of Q3 2025, which was up 8466.47% from -$164804.0 recorded in Q2 2025.
  • China Pharma Holdings' Change in Inventory's 5-year high stood at $552686.0 during Q1 2023, with a 5-year trough of -$679042.0 in Q2 2021.
  • Over the past 5 years, China Pharma Holdings' median Change in Inventory value was -$211393.0 (recorded in 2021), while the average stood at -$193160.5.
  • In the last 5 years, China Pharma Holdings' Change in Inventory plummeted by 633519.71% in 2021 and then soared by 31180.69% in 2022.
  • Quarter analysis of 5 years shows China Pharma Holdings' Change in Inventory stood at -$255815.0 in 2021, then grew by 24.59% to -$192902.0 in 2022, then plummeted by 34.09% to -$258659.0 in 2023, then plummeted by 97.56% to -$510996.0 in 2024, then soared by 88.69% to -$57779.0 in 2025.
  • Its Change in Inventory was -$57779.0 in Q3 2025, compared to -$164804.0 in Q2 2025 and -$156627.0 in Q1 2025.